Ampio Pharmaceuticals Inc (AMPE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

373 INVERNESS PARKWAY ENGLEWOOD, CO 80112

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs.

Data based on most recent fiscal year report
Market Cap106.296 Million Shares Outstanding158.65 Million Avg Volume1.104 Million
1-Yr BETA vs S&P TR0.738 Current Ratio5.8 Quick Ratio5.8
View SEC Filings from AMPE instead.

View recent insider trading info

Funds Holding AMPE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMPE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACALUSO MICHAEL CEO

0 2020-01-10 1

STEVENS DAVID R

121,049 2020-01-02 3

COELHO PHILIP H

189,987 2020-01-02 3

GILES RICHARD B

353,608 2020-01-02 3

BAR-OR DAVID

79,287 2020-01-02 3

STOKELY DAN CFO

0 2020-01-02 4

DISBROW JOSHUA R. CHIEF EXECUTIVE OFFICER

525,048 2019-12-19 0

GOULD GREGORY A CHIEF FINANCIAL OFFICER

  • Officer
450,000 2019-12-10 0

CHEREVKA HOLLI CHIEF OPERATING OFFICER

0 2019-09-16 1

CHILCOTT, III THOMAS E. CHIEF FINANCIAL OFFICER

  • Officer
0 2018-10-01 0

CLIFT VAUGHAN LENNOX CHIEF REGULATORY AFFAIRS

  • Officer
0 2015-07-31 0

MCGREGOR MARK D CHIEF FINANCIAL OFFICER

  • Officer
0 2013-11-08 0

WINGERTER DONALD B JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
325,000 2011-05-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MACALUSO MICHAEL CEO

2020-01-10 A 200,000 a 200,000 0.00 direct

GILES RICHARD B

2020-01-02 A 34,059 $0.59 a 301,353 353,608.00 direct

COELHO PHILIP H

2020-01-02 A 34,059 $0.59 a 189,987 189,987.00 direct

STOKELY DAN CFO

2020-01-02 A 30,000 a 30,000 0.00 direct

STEVENS DAVID R

2020-01-02 A 34,059 $0.59 a 121,049 121,049.00 direct

BAR-OR DAVID

2020-01-02 A 34,059 $0.59 a 79,287 79,287.00 direct

COELHO PHILIP H

2019-12-19 A 36,000 a 36,000 0.00 direct

GILES RICHARD B

2019-12-19 A 36,000 a 36,000 0.00 direct

STEVENS DAVID R

2019-12-19 A 36,000 a 36,000 0.00 direct

BAR-OR DAVID

2019-12-19 A 36,000 a 36,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments